DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹47,594 Cr | ₹37,806 Cr | ₹31,580 Cr | ₹28,470 Cr | ₹25,548 Cr |
What is the latest Total Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹47,594 Cr |
| Mar2024 | ₹37,806 Cr |
| Mar2023 | ₹31,580 Cr |
| Mar2022 | ₹28,470 Cr |
| Mar2021 | ₹25,548 Cr |
How is Total Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹47,594 Cr | 25.89 | |
| Mar2024 | ₹37,806 Cr | 19.72 | |
| Mar2023 | ₹31,580 Cr | 10.92 | |
| Mar2022 | ₹28,470 Cr | 11.44 | |
| Mar2021 | ₹25,548 Cr | - | |
Compare Total Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹106,161.1 Cr | -0.1% | 2.3% | 2.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,705.0 Cr | -0.7% | 2% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,091.0 Cr | -2.1% | -2.8% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,555.0 Cr | -0.9% | -0.6% | 12.2% | Stock Analytics | |
| CIPLA | ₹120,919.0 Cr | -1% | -1.2% | 3.6% | Stock Analytics | |
| MANKIND PHARMA | ₹87,110.1 Cr | -2.6% | -5.1% | -20.2% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -0.1% |
2.3% |
2.6% |
| SENSEX | 0.2% |
-0.5% |
4% |
You may also like the below Video Courses